Clinical Trials Logo

Filter by:
NCT ID: NCT05576597 Recruiting - Clinical trials for Rheumatoid Arthritis

Effect of Butyrate Supplement on Rheumatoid Arthritis

Start date: August 23, 2022
Phase: Phase 2
Study type: Interventional

This study is a pilot study to evaluate the safety and efficacy of administering butyrate supplement on rheumatoid arthritis patients. Ten participants will be included to receive butyrate supplement for 12 weeks. Changes of immune cell subtypes, markers of intestinal damage, intestinal flora and other laboratory indicators will be monitored.

NCT ID: NCT05576584 Recruiting - Pharmacokinetics Clinical Trials

Safety, Tolerability and Pharmacokinetic Characteristics Evaluation on GST-HG121 Tablets

Start date: July 19, 2022
Phase: Phase 1
Study type: Interventional

This phase I clinical study is a phase I clinical study on the safety, tolerability, pharmacokinetic characteristics and food effects of single / continuous administration in Chinese adult healthy subjects

NCT ID: NCT05576532 Recruiting - Safety Clinical Trials

Venetoclax Plus IM2 Regimen for Relapsed and Refractory T Lymphoblastic Lymphoma/Leukemia

Start date: January 10, 2023
Phase: Phase 2
Study type: Interventional

To evaluate the safety and efficacy of Venetoclax plus IM2 regimen for relapsed and refractory T lymphoblastic lymphoma/leukemia. Dosage of Venetoclax:100mg/d-400mg/d(dose adjustment when concomitant used with CYP3A inhibitor) for 1-28 days (at least 7 days); IM2 regimen: Ifosfamide 1-1.5g/m2/d for 5 days; Mitoxantrone 6-8g/m2/d for 3 days( or Liposome mitoxantrone 20mg/m2 d1 or Idarubicin 6-8mg/m2/d for 3 days) ;methotrexate 1-1.5g/m2/d for 1 day;

NCT ID: NCT05576506 Recruiting - Clinical trials for Colorectal Neoplasms

Application of Hyperspectral Imaging Analysis Technology in the Diagnosis of Colorectal Cancer Based on Colonoscopic Biopsy

Start date: October 8, 2022
Phase:
Study type: Observational

The purpose of this study is to develop and validate a deep learning algorithm for the diagnosis of colorectal cancer other colorectal disease by marking and analyzing the characteristics of hyperspectral images based on the pathological results of colonoscopic biopsy, so as to improve the objectiveness and intelligence of early colorectal cancer diagnosis.

NCT ID: NCT05575986 Recruiting - Trombocitopenia Clinical Trials

Herombopag Olamine in the Treatment of Thrombocytopenia After Chemotherapy

hetrombopag
Start date: October 2022
Phase: Phase 4
Study type: Interventional

To evaluate the efficacy and safety of hetrombopag in the treatment of thrombocytopenia after chemotherapy in patients with digestive system malignant tumors

NCT ID: NCT05575804 Recruiting - Clinical trials for Advanced/ Metastatic Her-2 Positive Breast Cancer

GQ1001 Combined With Pyrotinib for Treatment With HER2 Positive Metastatic Breast Cancer

Start date: October 1, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

The aim of this trial is to study the safety, pharmacokinetics and preliminary efficacy of the HER2-targeted antibody-drug conjugate GQ1001 in combination with pyrotinib in patients with HER2-positive metastatic breast cancer patients who had failed previous anti-HER2 treatment.

NCT ID: NCT05575726 Recruiting - Clinical trials for Chronic Respiratory Disease

Effects of Neutrophil Extracellular Traps and Damage-associated Molecular Pattern Molecules on Long Term Use of Macrolides in Adults With Chronic Respiratory Disease

Start date: August 1, 2021
Phase:
Study type: Observational

The purpose of this study is to investigate the effects of neutrophil extracellular traps and damage-associated molecular pattern molecules on long term use of macrolides in adults with chronic respiratory disease.

NCT ID: NCT05575713 Recruiting - Clinical trials for Major Depressive Disorder

The Effect of Soluble Epoxide Hydrolase (SEH) on Depression

Start date: June 1, 2019
Phase:
Study type: Observational

Depression is the most common mental disease and the second leading cause of chronic disease burden, which is closely related to suicidal behavior. The diagnosis and treatment of depression still lack of effective biological indicators, and about 30% of patients with depression still can not relieve their depressive symptoms after treatment. Previous studies have found that ATP release from astrocytes plays an important role in the occurrence, development and treatment of depression. Epoxy eicosotrienes (eets) are closely related to the function of the nervous system and may be the pathophysiological mechanism of depression. Soluble epoxide hydrolase (SEH) can regulate ATP release by affecting EET degradation, leading to depression like behavior and antidepressant effect, and sEH is closely related to cognitive function of depression.

NCT ID: NCT05575661 Recruiting - Clinical trials for Post-induction Hypotension

Correlation Between Postprandial Hypotension and Post-induction Hypotension in the Elderly.

Start date: November 7, 2022
Phase:
Study type: Observational

Postprandial hypotension (PPH) and post-induction hypotension (PIH) are very common in the elderly population and are associated with a variety of poor outcomes.The purpose of this study is to investigate the correlation between PPH and perioperative adverse events such as PIH in the elderly.

NCT ID: NCT05575622 Recruiting - Clinical trials for Hepatocellular Carcinoma

Clinical Study for Combined Analysis of CTC and Exosomes on Predicting the Efficacy of Immunotherapy in Patients With Hepatocellular Carcinoma

Start date: January 1, 2023
Phase:
Study type: Observational

This project intends to perform CTC PD-L1 imaging, exosomal PD-L1 protein detection, and exosomal LAG-3 protein detection, so as to resolve the functional marker profiles of immunotherapy in the peripheral blood of HCC patients and comprehensively present the responsiveness of patients to immunotherapy.